![]()
|
|
||||||||
(Received for publication, March 12, 1997, and in revised form, May 21, 1997)
From the Biophysics Research Institute, Medical College of
Wisconsin, Milwaukee, Wisconsin 53226
1-Substituted diazen-1-ium-1,2-diolates, a class
of nitric oxide (·NO) donor compounds that spontaneously release
·NO at different rates, were used to investigate the effect of ·NO release rate upon the oxidation of low density lipoprotein (LDL). All donor compounds conferred an inhibitory effect upon the
oxidation of LDL; however, the effect exhibited a biphasic dependence
upon the rate of ·NO release. The ·NO release rate that
maximally inhibited oxidation was dependent upon the rate of oxidation.
When LDL was rapidly oxidized by copper(II) sulfate, a faster release
rate was more effective. In contrast, when LDL was oxidized slowly by
2,2
-azobis-2-amidinopropane hydrochloride, a slower release rate was
most effective. This biphasic relationship between ·NO release
rate and the duration of inhibition was also demonstrated when LDL
oxidation was initiated with
5-amino-3-(4-morpholinyl)-1,2,3-oxadiazolium, a peroxynitrite
generator. We conclude that the antioxidant ability of ·NO is
dependent not only upon the rate of its release from ·NO donors,
but also upon the rate of oxidation. This conclusion is supported by a
kinetic model of LDL oxidation in the presence of ·NO.
This article has been cited by other articles:
![]() |
M. Moller, H. Botti, C. Batthyany, H. Rubbo, R. Radi, and A. Denicola Direct Measurement of Nitric Oxide and Oxygen Partitioning into Liposomes and Low Density Lipoprotein J. Biol. Chem., March 11, 2005; 280(10): 8850 - 8854. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kalyanaraman Nitrated lipids: A class of cell-signaling molecules PNAS, August 10, 2004; 101(32): 11527 - 11528. [Full Text] [PDF] |
||||
![]() |
J. Ou, J. T. Fontana, Z. Ou, D. W. Jones, A. W. Ackerman, K. T. Oldham, J. Yu, W. C. Sessa, and K. A. Pritchard Jr. Heat shock protein 90 and tyrosine kinase regulate eNOS NO{middle dot} generation but not NO{middle dot} bioactivity Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H561 - H569. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Galijasevic, G. M. Saed, M. P. Diamond, and H. M. Abu-Soud Myeloperoxidase up-regulates the catalytic activity of inducible nitric oxide synthase by preventing nitric oxide feedback inhibition PNAS, December 9, 2003; 100(25): 14766 - 14771. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kotamraju, Y. Tampo, A. Keszler, C. R. Chitambar, J. Joseph, A. L. Haas, and B. Kalyanaraman Nitric oxide inhibits H2O2-induced transferrin receptor-dependent apoptosis in endothelial cells: Role of ubiquitin-proteasome pathway PNAS, September 16, 2003; 100(19): 10653 - 10658. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ou, J. Ou, A. W. Ackerman, K. T. Oldham, and K. A. Pritchard Jr L-4F, an Apolipoprotein A-1 Mimetic, Restores Nitric Oxide and Superoxide Anion Balance in Low-Density Lipoprotein-Treated Endothelial Cells Circulation, March 25, 2003; 107(11): 1520 - 1524. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Abudara, A. F. Alvarez, M. H. Chase, and F. R. Morales Nitric Oxide as an Anterograde Neurotransmitter in the Trigeminal Motor Pool J Neurophysiol, July 1, 2002; 88(1): 497 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Kuhlencordt, R. Gyurko, F. Han, M. Scherrer-Crosbie, T. H. Aretz, R. Hajjar, M. H. Picard, and P. L. Huang Accelerated Atherosclerosis, Aortic Aneurysm Formation, and Ischemic Heart Disease in Apolipoprotein E/Endothelial Nitric Oxide Synthase Double-Knockout Mice Circulation, July 24, 2001; 104(4): 448 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Kuhlencordt, J. Chen, F. Han, J. Astern, and P. L. Huang Genetic Deficiency of Inducible Nitric Oxide Synthase Reduces Atherosclerosis and Lowers Plasma Lipid Peroxides in Apolipoprotein E-Knockout Mice Circulation, June 26, 2001; 103(25): 3099 - 3104. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Patel, A.-L. Levonen, J. H. Crawford, and V. M. Darley-Usmar Mechanisms of the pro- and anti-oxidant actions of nitric oxide in atherosclerosis Cardiovasc Res, August 18, 2000; 47(3): 465 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Carr, M. R. McCall, and B. Frei Oxidation of LDL by Myeloperoxidase and Reactive Nitrogen Species : Reaction Pathways and Antioxidant Protection Arterioscler. Thromb. Vasc. Biol., July 1, 2000; 20(7): 1716 - 1723. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Hazen, R. Zhang, Z. Shen, W. Wu, E. A. Podrez, J. C. MacPherson, D. Schmitt, S. N. Mitra, C. Mukhopadhyay, Y. Chen, et al. Formation of Nitric Oxide-Derived Oxidants by Myeloperoxidase in Monocytes : Pathways for Monocyte-Mediated Protein Nitration and Lipid Peroxidation In Vivo Circ. Res., November 12, 1999; 85(10): 950 - 958. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Abu-Soud and S. L. Hazen Nitric Oxide Is a Physiological Substrate for Mammalian Peroxidases J. Biol. Chem., November 22, 2000; 275(48): 37524 - 37532. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kotamraju, N. Hogg, J. Joseph, L. K. Keefer, and B. Kalyanaraman Inhibition of Oxidized Low-density Lipoprotein-induced Apoptosis in Endothelial Cells by Nitric Oxide. PEROXYL RADICAL SCAVENGING AS AN ANTIAPOPTOTIC MECHANISM J. Biol. Chem., May 11, 2001; 276(20): 17316 - 17323. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Denicola, C. Batthyany, E. Lissi, B. A. Freeman, H. Rubbo, and R. Radi Diffusion of Nitric Oxide into Low Density Lipoprotein J. Biol. Chem., January 4, 2002; 277(2): 932 - 936. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |